Company Filing History:
Years Active: 2021
Title: Innovations in Diagnostic Methods by Omar Rifaie Graham
Introduction
Omar Rifaie Graham is an innovative inventor based in Marly, Switzerland. He has made significant contributions to the field of diagnostics, particularly in the detection and quantification of blood-related diseases. His work focuses on utilizing advanced methods that can be applied in various healthcare settings.
Latest Patents
Omar Rifaie Graham holds a patent for a diagnostic method designed for the detection and quantification of blood-related diseases or conditions. This method employs biomarkers, such as hemoglobin and hemozoin, as catalysts in an atom transfer radical polymerization (ATRP) reaction. The reaction is performed above a lower critical solution temperature (LCST) of a polymer, allowing the polymerization process to be monitored by the rate of turbidity formation. The correlation between the rate of turbidity formation and the concentration of the biomarker makes this technique a valuable quantitative tool, suitable for point-of-care tests in the field.
Career Highlights
Omar Rifaie Graham is affiliated with the Adolphe Merkle Institute at the University of Fribourg. His work at this prestigious institution has allowed him to explore innovative solutions in the realm of diagnostics. His research has the potential to significantly impact the way blood-related diseases are diagnosed and monitored.
Collaborations
Omar has collaborated with notable colleagues, including Nico Bruns and Jonas Pollard. These partnerships have fostered a collaborative environment that enhances the research and development of diagnostic methods.
Conclusion
Omar Rifaie Graham's contributions to diagnostic methods represent a significant advancement in the detection and quantification of blood-related diseases. His innovative approach and dedication to research continue to pave the way for improved healthcare solutions.